SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-083471
Filing Date
2024-04-01
Accepted
2024-04-01 16:34:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d761542ddefa14a.htm DEFA14A 11244
2 GRAPHIC g761542g02g02.jpg GRAPHIC 399728
3 GRAPHIC g761542g03g03.jpg GRAPHIC 270193
  Complete submission text file 0001193125-24-083471.txt   935429
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36407 | Film No.: 24810011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)